# Healthcare Costs: Current State

## Overview

The United States spends more on healthcare than any other nation—both in absolute terms and as a share of GDP—yet achieves worse outcomes on most measures. Total healthcare spending exceeds $4.5 trillion annually (18% of GDP), with costs continuing to grow faster than inflation and wages.

---

## National Spending

### Total Healthcare Expenditures

| Year | Total Spending | GDP Share | Per Capita |
|------|----------------|-----------|------------|
| 2000 | $1.4 trillion | 13.3% | $4,878 |
| 2010 | $2.6 trillion | 17.3% | $8,412 |
| 2020 | $4.1 trillion | 19.7% | $12,530 |
| 2023 | $4.5 trillion | 17.6% | $13,493 |

### Spending by Category

| Category | Annual Spending | Share | Growth Rate (2023) |
|----------|-----------------|-------|-------------------|
| Hospital care | $1.4 trillion | 31% | 4.5% |
| Physician/clinical services | $885 billion | 20% | 3.8% |
| Prescription drugs | $405 billion | 9% | 7.8% |
| Nursing care facilities | $200 billion | 4% | 3.2% |
| Home health care | $140 billion | 3% | 5.1% |
| Dental services | $165 billion | 4% | 4.2% |
| Other professional services | $130 billion | 3% | 4.0% |
| Administrative costs | $500+ billion | 11%+ | 5.0% |
| Other (equipment, public health) | $680 billion | 15% | varies |

### Who Pays

| Payer | Share of Spending | Annual Amount |
|-------|-------------------|---------------|
| Private insurance | 29% | $1.3 trillion |
| Medicare | 22% | $990 billion |
| Medicaid | 18% | $810 billion |
| Out-of-pocket | 10% | $450 billion |
| Other government (VA, CHIP, etc.) | 14% | $630 billion |
| Other private | 7% | $315 billion |

---

## Price Levels

### International Comparison

| Category | U.S. Price | OECD Average | Ratio |
|----------|------------|--------------|-------|
| Hospital day | $5,220 | $765 | 6.8x |
| CT scan | $896 | $97 | 9.2x |
| MRI | $1,119 | $130 | 8.6x |
| Angioplasty | $32,200 | $6,400 | 5.0x |
| Hip replacement | $29,067 | $7,000 | 4.2x |
| Brand drug (avg) | 3.4x | Baseline | 3.4x |
| Physician visit | $190 | $35 | 5.4x |

### Domestic Price Variation

| Procedure | Highest Market | Lowest Market | Ratio |
|-----------|----------------|---------------|-------|
| Hospital stay (per day) | $5,200 (CA) | $1,800 (MS) | 2.9x |
| Hip replacement | $75,000 | $15,000 | 5.0x |
| MRI scan | $3,500 | $400 | 8.8x |
| C-section | $35,000 | $8,000 | 4.4x |
| Colonoscopy | $8,500 | $1,000 | 8.5x |

---

## Cost Drivers

### Major Categories

**Hospital Costs**

| Driver | Contribution |
|--------|--------------|
| Labor costs | 55% of hospital costs |
| Supplies and drugs | 15% |
| Capital and equipment | 10% |
| Administrative overhead | 15% |
| Profit/surplus | 5% |

**Pharmaceutical Costs**

| Drug Type | Growth Rate | Key Drivers |
|-----------|-------------|-------------|
| Brand drugs | 5-10%/year | Patent protection, no negotiation |
| Specialty drugs | 10%+/year | Biologics, rare disease |
| Generic drugs | Variable | Usually declining, occasional spikes |
| Biosimilars | Growing market | Competition emerging |

**Administrative Costs**

| Category | U.S. | Peer Countries |
|----------|------|----------------|
| Share of spending | 34.2% | 15-20% |
| Billing/coding staff | High | Lower |
| Prior authorization | Extensive | Limited |
| Insurer overhead | 15-20% | 2-5% |

### Consolidation Effects

**Hospital Market Concentration**

| Metric | Status |
|--------|--------|
| Markets highly concentrated (HHI >2,500) | 75%+ |
| Average price increase post-merger | 20-40% |
| Quality improvement post-merger | Minimal evidence |

**Physician Practice Consolidation**

| Metric | 2012 | 2022 |
|--------|------|------|
| Hospital-employed physicians | 26% | 52% |
| Independent practices | 53% | 37% |
| Practice sites owned by hospitals | 26% | 52% |

---

## Household Impact

### Premium Costs

| Coverage Type | 2013 | 2023 | Change |
|---------------|------|------|--------|
| Individual premium | $5,884 | $8,435 | +43% |
| Family premium | $16,351 | $23,968 | +47% |
| Employer share | ~75% | ~73% | Declining |
| Employee share | ~25% | ~27% | Rising |

### Cost-Sharing

| Metric | 2013 | 2023 | Change |
|--------|------|------|--------|
| Average deductible | $1,135 | $1,735 | +53% |
| Workers with deductible >$2,000 | 18% | 31% | +72% |
| Out-of-pocket max (ACA) | $6,350 | $9,450 | +49% |

### Financial Burden

| Measure | Prevalence |
|---------|------------|
| Adults delaying care due to cost | 29% |
| Adults skipping medications due to cost | 21% |
| Adults with medical debt | 41% |
| Medical debt affecting credit | 43 million |
| Medical bankruptcy (estimated share) | 60%+ |

---

## Geographic Variation

### Medicare Spending Variation

| Region | Per Beneficiary | Relative to National Average |
|--------|-----------------|------------------------------|
| Miami, FL | $16,351 | 1.45x |
| McAllen, TX | $14,841 | 1.31x |
| National average | $11,321 | 1.00x |
| Rochester, MN | $8,924 | 0.79x |
| Grand Junction, CO | $7,583 | 0.67x |

### Commercial Price Variation

| Market | Hospital Price Level | Relative |
|--------|---------------------|----------|
| Northern California | Highest | 2.0x average |
| New York City | Very high | 1.6x average |
| Dallas | Average | 1.0x |
| Grand Rapids, MI | Below average | 0.8x |
| Baltimore | Lower | 0.7x average |

---

## Recent Trends

### Post-COVID Developments

| Trend | Impact |
|-------|--------|
| Hospital labor costs | Sharp increase due to shortages |
| Telehealth | Expanded access, mixed cost effects |
| Consolidation | Accelerated in pandemic |
| Private equity | Increased healthcare acquisitions |
| Surprise billing | No Surprises Act implemented |

### Policy Changes

| Policy | Year | Effect |
|--------|------|--------|
| No Surprises Act | 2022 | Reduced surprise out-of-network bills |
| Hospital price transparency | 2021 | Compliance improving, impact limited |
| Medicare drug negotiation (IRA) | 2022 | First 10 drugs selected, savings begin 2026 |
| Insulin price cap | 2022 | $35/month for Medicare beneficiaries |

### Market Dynamics

| Trend | Direction | Cost Impact |
|-------|-----------|-------------|
| Hospital consolidation | Continuing | Upward |
| Physician employment | Increasing | Upward |
| Private equity acquisitions | Growing | Upward |
| Biosimilar adoption | Increasing | Downward |
| Generic competition | Steady | Downward |
| Specialty drug launches | Growing | Upward |

---

## System Performance

### Value Metrics

| Measure | U.S. | Peer Country Average |
|---------|------|----------------------|
| Life expectancy | 76.4 years | 82.0 years |
| Infant mortality | 5.4/1,000 | 3.5/1,000 |
| Preventable deaths | 336/100k | 200/100k |
| Obesity rate | 42% | 20-25% |
| Diabetes prevalence | 11% | 6-8% |

### Administrative Burden

| Metric | U.S. Status |
|--------|-------------|
| Prior authorization per practice | 40 hours/week |
| Billing/insurance FTEs per physician | 1.0+ |
| Revenue cycle management industry | $20+ billion |
| Claims denial rate | 10-15% |

---

## Vulnerable Populations

### Who Bears the Greatest Burden

| Population | Cost Impact |
|------------|-------------|
| Uninsured | 3x higher prices, no negotiated rates |
| Underinsured | High deductibles, medication rationing |
| Chronic disease patients | Ongoing high costs |
| Rural residents | Higher prices, travel costs |
| Low-income workers | High burden relative to income |
| Elderly on fixed income | Medicare gaps, Part D costs |

---

## Sources

- CMS National Health Expenditure data (2023).
- Kaiser Family Foundation Employer Health Benefits Survey.
- OECD Health Statistics.
- Health Care Cost Institute price data.
- Dartmouth Atlas of Health Care variation data.
- Commonwealth Fund international comparisons.
- RAND Hospital Price Transparency Study.

---

## Document Navigation

- Previous: [Overview](01-overview.md)
- Next: [History](03-history.md)
